Abacus Bioscience

Developer of immunotherapeutics for treating cancer and viral diseases

placeSeattle, Washington, United States calendar_todayFounded 2015 groups7 employees language abacusbioscience.com

Registered entities

Innovation

2 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 434 times.

YearFilings
20222
20231
20241
20252

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon